|
|
Expression of long non-coding RNA tumor protein translationally-controlled regulator 1-antisenseRNA1 in glioma and its effect on cell proliferation and invasion |
LIU Zhenjie1 LI Xin1 LU Jing2 LIANG Liang1 HU Yaowen1 XIE Jing1 ZHAO Xingang3 YANG Jiankai4 |
1.Department of Neurosurgery, Baoding NO.1 Central Hospital, Hebei Province, Baoding 071000, China;
2.Department of Internal Medicine, Baoding Orthopaedic Hospital, Hebei Province, Baoding 071000, China;
3.Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China;
4. Department of Neurosurgery, Second Hospital of Hebei Medical University, Hebei Province, Shijiazhuang 050000, China |
|
|
Abstract Objective To investigate the effect of long non-coding RNA (lncRNA) tumor protein translation regulator 1-antisense RNA1 (TPT1-AS1) on the proliferation and invasion of glioma cells U251. Methods U251 cells were divided into blank control group, negative transfection group, and TPT1-AS1 overexpression group. The blank control group was not treated, and the other two groups were transfected with corresponding plasmids. After 48 hours of transfection, the expression level of TPT1-AS1 in U251 cells of each group was compared; MTT assay was used to determine the proliferation ability of U251 cells; flow cytometry was used to detect the apoptotic ability of U251 cells; Transwell chamber assay was used to detect the invasion ability of U251 cells; scratch test was used to detect the migration ability of U251 cells; the expression of apoptosis (Caspase-3, Bax, Bcl-2) and invasion (matrix metallo proteinases [MMP]-2, MMP-9) related proteins was detected by Western blot. Results There were no significant differences in TPT1-AS1 expression, cell survival rate, cell apoptosis rate, number of invasive cells, scratch healing rate, and protein expressions of Caspase-3, Bax, Bcl-2, MMP-2, and MMP-9 between negative control group and blank control group (P>0.05). TPT1-AS1 expression level, apoptosis capacity, Caspase-3, and Bax protein expression in TPT1-AS1 overexpression group were higher than those in blank control group, and the differences were statistically significant (P<0.05). The expression of Bcl-2 protein, cell survival rate, invasion, migration ability, and invasion-related protein in TPT1-AS1 overexpression group were lower than those in blank control group, with statistical significance (P<0.05). Conclusion TPT1-AS1 has low expression in U251, and high expression of TPT1-AS1 can inhibit the proliferation and invasion of glioma cells.
|
|
|
|
|
[1] Poonan P,Agoni C,Ibrahim MAA,et al. Glioma-Targeted Therapeutics:Computer-Aided Drug Design Prospective [J]. Protein J,2021,40(5):601-655.
[2] Wen PY,Stein A,van den Bent M,et al. Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR):a multicentre,open-label,single-arm,phase 2,basket trial [J]. Lancet Oncol,2022,23(1):53-64.
[3] Li L,Chen J,Ming Y,et al. The Application of Peptides in Glioma: A Novel Tool for Therapy[J]. Curr Pharm Biotechnol,2022,23(5):620-633.
[4] Liu L,Xu Q,Xiong Y,et al. LncRNA LINC01094 contributes to glioma progression by modulating miR-224- 5p/CHSY1 axis [J]. Hum Cell,2022,35(1):214-225.
[5] Zhou Q,Liu ZZ,Wu H,et al. LncRNA H19 Promotes Cell Proliferation,Migration,and Angiogenesis of Glioma by Regulating Wnt5a/β-Catenin Pathway via Targeting miR-342 [J]. Cell Mol Neurobiol,2022,42(4):1065-1077.
[6] Hu C,Fang K,Zhang X,et al. Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancer [J]. Pathol Res Pract,2020,216(11):153216.
[7] Wang W,Yang F,Zhang L,et al. LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas [J]. Oncotarget,2016,7(47):77225-77236.
[8] Jia L,Song Y,Mu L,et al. Long noncoding RNA TPT1-AS1 downregulates the microRNA-770-5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation [J]. J Cell Physiol,2020,235(4):3679-3689.
[9] Di W,Fan W,Wu F,et al. Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples [J]. Cancer Sci,2022,113(2):756- 769.
[10] Barthel L,Hadamitzky M,Dammann P,et al. Glioma: molecular signature and crossroads with tumor microenvironment [J]. Cancer Metastasis Rev,2022,41(1):53-75.
[11] Grammatikakis I,Lal A. Significance of lncRNA abundance to function [J]. Mamm Genome,2022,33(2):271-280.
[12] Reggiardo RE,Maroli SV,Kim DH. LncRNA Biomarkers of Inflammation and Cancer [J]. Adv Exp Med Biol,2022, 1363(19):121-145.
[13] 方新鑫,孙明军,宫月华.lncRNA TPT1-AS1在正常与胃癌组织中的差异表达及其诊断、预后价值的评价[J].胃肠病学和肝病学杂志,2019,28(10):1113-1116.
[14] 王伟,温英武,高双友,等.LncRNA TPT1-AS1在前列腺癌中的表达及对生物学功能的影响[J].中国药师,2020, 23(5):793-797,803.
[15] Zhang Y,Sun J,Qi Y,et al. Long non-coding RNA TPT1- AS1 promotes angiogenesis and metastasis of colorectal cancer through TPT1-AS1/NF90/VEGFA signaling pathway [J]. Aging (Albany NY),2020,12(7):6191-6205.
[16] Wu W,Gao H,Li X,et al. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression [J]. Cancer Sci,2019,110(5):1587-1598.
[17] Li X,Shi L,Li Y,et al. The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles [J]. Artif Cells Nanomed Biotechnol,2020, 48(1):983-996.
[18] 万昕,胡月,章菊,等.HHV-6A感染对神经胶质瘤细胞LncRNA MEG3表达及增殖凋亡侵袭转化的影响[J].癌变·畸变·突变,2019,31(5):352-358.
[19] 上官文兵,李朝晖,张佳琦,等.LncRNA FOXD2-AS1对胶质瘤细胞增殖及迁移能力的影响[J].中国实验诊断学,2019,23(3):525-527.
[20] Zhang QL,Yang JJ,Zhang HS. Carvedilol (CAR) com
bined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress,inflammation,apoptosis and autophagy [J]. Biomed Pharmacother,2019,109(12):71-83.
[21] Elblehi SS,El-Sayed YS,Soliman MM,et al. Date Palm Pollen Extract Avert Doxorubicin-Induced Cardiomyopathy Fibrosis and Associated Oxidative/Nitrosative Stress,Inflammatory Cascade,and Apoptosis-Targeting Bax/Bcl-2 and Caspase-3 Signaling Pathways [J]. Animals (Basel),2021,11(3):886-897.
[22] Jiang T,Ma X,Chen H,et al. Diazepam ameliorated myocardial ischemia-reperfusion injury via inhibition of C-C chemokine receptor type 2/tumor necrosis factor-alpha/interleukins and Bcl-2-associated X protein/caspase-3 pathways in experimental rats [J]. J Vet Med Sci,2021,83(12):1965-1976.
[23] Morales-Vásquez F,Castillo-Sánchez R,Gómora MJ,et al. Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors [J]. J Ovarian Res,2020,13(1):86-98.
[24] Shen J,Song JB,Fan J,et al. Distribution and Dynamic Changes in Matrix Metalloproteinase (MMP)-2,MMP-9,and Collagen in an In Stent Restenosis Process [J]. Eur J Vasc Endovasc Surg,2021,61(4):648-655.
[25] Song Z,Wang J,Su Q,et al. The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma. Braz J Otorhinolaryngol [J]. 2021,87(5):521-528.
[26] Manola I,Mataic A,Drvar DL,et al. Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin [J]. In Vivo,2020,34(3):1271-1275. |
|
|
|